Literature DB >> 15621138

Ischemic-type biliary lesions in liver transplant recipients: evaluation with magnetic resonance cholangiography.

P Boraschi1, F Donati, R Gigoni, L Urbani, M Femia, M C Cossu, F Filipponi, F Falaschi.   

Abstract

We assessed the diagnostic value of magnetic resonance cholangiography (MRC) when evaluating ischemic-type biliary lesions in the follow-up of liver transplant patients. We retrospectively reviewed magnetic resonance imaging and MRC of 28 liver transplant recipients with ischemic changes of the biliary tree. The MR examinations were performed at 1.5 T. After the acquisition of axial T1w and T2w sequences, MRC involved a coronal respiratory-triggered, fat-suppressed, two-dimensional, thin-slab, heavily T2w fast spin-echo sequence, and/or a coronal breath-hold, thin- and thick-slab, single-shot T2w sequence. Eleven patients underwent either surgical reconstruction of the biliary system (n = 4) or liver retransplantation (n = 7); the pathologic specimens were employed as standard of reference. The final diagnosis was obtained through direct cholangiography in the remaining cases. Without knowledge of the surgical, pathologic, and cholangiographic findings, two experienced investigators evaluated in conference the MR images to determine the presence of biliary tract abnormalities. MRC demonstrated strictures involving the hepatic bifurcation and the extrahepatic bile duct of the graft in 26 patients; a concomitant thickening of the biliary wall was described in 18 out of these 26 subjects. MRC also showed sludge or stones formation in the donor common bile duct in 16 out of these patients. In conclusion, MRC allows noninvasive, reliable, assessment of ischemic-type biliary lesions in liver transplant recipients.

Entities:  

Mesh:

Year:  2004        PMID: 15621138     DOI: 10.1016/j.transproceed.2004.09.038

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

Review 1.  Postoperative biliary adverse events following orthotopic liver transplantation: assessment with magnetic resonance cholangiography.

Authors:  Piero Boraschi; Francescamaria Donati
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 2.  Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis.

Authors:  Jennifer E Jorgensen; Akbar K Waljee; Michael L Volk; Christopher J Sonnenday; Grace H Elta; Mahmoud M Al-Hawary; Amit G Singal; Jason R Taylor; B Joseph Elmunzer
Journal:  Gastrointest Endosc       Date:  2011-02-12       Impact factor: 9.427

3.  Establishment of an animal model of ischemic type intrahepatic biliary lesion in rabbits.

Authors:  Qin-Song Sheng; Da-Zhi Chen; Ren Lang; Qiang He; Yong-Jiu Yang; Zhao-Wei Qu; De-Fang Zhao; Xiao-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 4.  Multimodality postoperative imaging of liver transplantation.

Authors:  Giulia A Zamboni; Ivan Pedrosa; Jonathan B Kruskal; Vassilios Raptopoulos
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

5.  Delayed rearterialization unlikely leads to nonanastomotic stricture but causes temporary injury on bile duct after liver transplantation.

Authors:  Yang Liu; Jiazhong Wang; Peng Yang; Hongwei Lu; Le Lu; Jinlong Wang; Hua Li; Yanxia Duan; Jun Wang; Yiming Li
Journal:  Transpl Int       Date:  2014-12-01       Impact factor: 3.782

6.  New diagnosis and therapy model for ischemic-type biliary lesions following liver transplantation--a retrospective cohort study.

Authors:  Ying-cai Zhang; En-ze Qu; Jie Ren; Qi Zhang; Rong-qin Zheng; Yang Yang; Gui-hua Chen
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

7.  Biliary complications following orthotopic liver transplantation: May contrast-enhanced MR Cholangiography provide additional information?

Authors:  Piero Boraschi; Francescamaria Donati; Roberto Gigoni; Franco Filipponi
Journal:  Eur J Radiol Open       Date:  2016-06-06

8.  Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.

Authors:  Changjun Huang; Shanzhou Huang; Yunhua Tang; Qiang Zhao; Dongping Wang; Weiqiang Ju; Lu Yang; Jian Zhang; Linwei Wu; Maogen Chen; Zhiheng Zhang; Zebin Zhu; Linhe Wang; Caihui Zhu; Yixi Zhang; Chengjun Sun; Wei Xiong; Yuekun Shen; Xiaoxiang Chen; Yi Ma; Anbin Hu; Xiaofeng Zhu; Jian Rong; Changjie Cai; Zhiyong Guo; Xiaoshun He
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.